The company is highly regarded for producing high-quality mRNA and plasmid DNA, essential for cutting-edge applications in ...
Temperature-controlled supply chain solutions firm Cryoport has partnered with VGCI, a subsidiary of GeneOne Life Science, to ...
Exonucleases MarketThe global exonucleases market, valued at approximately USD 162.6 million in 2022, is on track for steady growth over the next decade. Forecasts indicate a compound annual growth ...
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and VGXI, Inc., ...
To improve traceability and enable authentication of synthetic nucleic acid sequences, researchers are embedding digital ...
Beijing Tsingke Biotech Co., Ltd. recently concluded a successful exhibition at CGTI2024 in Boston. This premier event ...
Centivax partners with BioCina to initiate cGMP manufacturing of revolutionary universal influenza vaccine: Adelaide, South Australia Monday, October 14, 2024, 11:00 Hrs [IST] Bio ...
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new ...
Nanotein Technologies is a Berkeley-based, Series-A biotechnology start-up manufacturing next generation reagents that expand and activate immune cells for Cell Therapy applications. Research use only ...
In lab experiments, bacteria transferred plasmids with AMR genes in the presence of zinc at reduced or nonexistent rates. Stopping the transfer without killing microbes may help reduce AMR without ...
Thierry Bordet, CSO of PulseSight Therapeutics, said, “EVER attracts top European researchers and the most innovative industry players, and I am delighted that we have been accepted to present our ...